Gillian Cannon
Director/Board Member en CORCEPT THERAPEUTICS INCORPORATED .
Fortuna: - $ al 31/03/2024
Perfil
Gillian M.
Cannon is currently serving as an Independent Director at Corcept Therapeutics, Inc., Director at Affibody AB, Director at Xenon Pharmaceuticals, Inc., Director at Edinburgh Innovations Ltd., and Head-Commercial Innovation at Roivant Sciences, Inc. She is also the President of Alyvant, Inc. Dr. Cannon has previously worked as the President-North American Operations at UCB, Inc. and Vice President-Commercial Operations at Merck BioVentures.
She has an undergraduate degree from The University of Edinburgh and doctorate degrees from Temple University (Pennsylvania) and Fox School of Business.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 10/08/2023 | 0 ( -.--% ) | - $ | 31/03/2024 | |
| 05/04/2024 | 0 ( -.--% ) | - $ | 31/03/2024 |
Cargos activos de Gillian Cannon
| Empresas | Cargo | Inicio |
|---|---|---|
| CORCEPT THERAPEUTICS INCORPORATED | Director/Board Member | 23/11/2020 |
| XENON PHARMACEUTICALS INC. | Director/Board Member | 08/08/2023 |
Affibody AB
 Affibody AB Miscellaneous Commercial ServicesCommercial Services Affibody AB conducts research and development services within biotechnology. It markets and sells licensed products and research findings to the pharmaceutical industry. The company was founded by Karin Nord in 1998 and is headquartered in Stockholm, Sweden. | Director/Board Member | 01/01/2019 |
| Alyvant, Inc. | President | 01/01/2018 |
Roivant Sciences, Inc.
 Roivant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Roivant Sciences, Inc. operates as a pharmaceutical firm. It develops and markets drugs. The firm specializes in uterine fibroids, endometriosis, prostate cancer, diabetes, and pulmonary arterial hypertension. The company was founded by Vivek Ramaswamy in 2014 and is headquartered in New York, NY. | Corporate Officer/Principal | 01/04/2020 |
Edinburgh Innovations Ltd.
 Edinburgh Innovations Ltd. Miscellaneous Commercial ServicesCommercial Services Edinburgh Innovations Ltd. engages in the provision of management service for the University of Edinburgh. The company is headquartered in Edinburgh, the United Kingdom. | Director/Board Member | 01/01/2020 |
Antiguos cargos conocidos de Gillian Cannon.
| Empresas | Cargo | Fin |
|---|---|---|
UCB, Inc.
 UCB, Inc. Financial ConglomeratesFinance Part of UCB SA, UCB, Inc. provides financial services. The private company is based in Smyrna, GA. The CEO of the company is Duane Barnes. | Corporate Officer/Principal | 01/01/2017 |
| Merck BioVentures | Corporate Officer/Principal | 01/01/2012 |
Formación de Gillian Cannon.
| The University of Edinburgh | Undergraduate Degree |
| Temple University (Pennsylvania) | Doctorate Degree |
| Fox School of Business | Doctorate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 2 |
|---|---|
| CORCEPT THERAPEUTICS INCORPORATED | Health Technology |
| XENON PHARMACEUTICALS INC. | Health Technology |
| Empresas privadas | 6 |
|---|---|
Affibody AB
Affibody AB Miscellaneous Commercial ServicesCommercial Services Affibody AB conducts research and development services within biotechnology. It markets and sells licensed products and research findings to the pharmaceutical industry. The company was founded by Karin Nord in 1998 and is headquartered in Stockholm, Sweden. | Commercial Services |
UCB, Inc.
UCB, Inc. Financial ConglomeratesFinance Part of UCB SA, UCB, Inc. provides financial services. The private company is based in Smyrna, GA. The CEO of the company is Duane Barnes. | Finance |
Edinburgh Innovations Ltd.
Edinburgh Innovations Ltd. Miscellaneous Commercial ServicesCommercial Services Edinburgh Innovations Ltd. engages in the provision of management service for the University of Edinburgh. The company is headquartered in Edinburgh, the United Kingdom. | Commercial Services |
| Merck BioVentures | |
Roivant Sciences, Inc.
Roivant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Roivant Sciences, Inc. operates as a pharmaceutical firm. It develops and markets drugs. The firm specializes in uterine fibroids, endometriosis, prostate cancer, diabetes, and pulmonary arterial hypertension. The company was founded by Vivek Ramaswamy in 2014 and is headquartered in New York, NY. | Health Technology |
| Alyvant, Inc. |
- Bolsa de valores
- Insiders
- Gillian Cannon
